Snowball logo
logo
3002

Zhejiang DiAn Diagnostics Co

300244 SHE
¥21.15¥0.00  (0%)
Estimate
P/E
100.7
EPS
0.21
Beta
0.693
Growth
Revenue, YoY
-5%
Net income, YoY
406.46%
FCF, YoY
16.06%
Forecast
P/E (FWD)
32.3
EPS (FWD)
0.655
Dividends
Dividend yield
1.65%
Annual payout
¥0.35
Next ex. div date
June 25, 27
Payout
189.21%
Div.growth, 5y
14.33%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
300244
ISIN
CNE1000015N1
Country
China
Sector (GICS)
Healthcare
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series. In addition, the company offers diagnostic product supply, medical testing services, supply chain optimization, digital operation management, laboratory quality system construction, and professional cold chain logistics services. Further, it is involved in the research and development of diagnostic products; and vitro diagnostic reagents, as well as forensic identification, health management, and other fields. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.

Frequently asked questions

What sector does Zhejiang DiAn Diagnostics Co (300244) operate in?

Zhejiang DiAn Diagnostics Co belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Zhejiang DiAn Diagnostics Co (300244) current stock price?

As of the latest data, Zhejiang DiAn Diagnostics Co stock price is CN¥21.15, with a previous close of CN¥21.15.

What is Zhejiang DiAn Diagnostics Co (300244) current market capitalization?

Zhejiang DiAn Diagnostics Co market cap is approximately 13.22 billion.

What is Zhejiang DiAn Diagnostics Co (300244) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.21, and the forward EPS is CN¥0.66.

What is Zhejiang DiAn Diagnostics Co (300244) Price-to-Earnings (P/E) ratio?

Zhejiang DiAn Diagnostics Co current P/E ratio is 100.71, with a forward P/E of 32.29.

Does Zhejiang DiAn Diagnostics Co (300244) pay dividends?

Yes. Zhejiang DiAn Diagnostics Co pays annual dividends with an annualized yield of 1.65% and an estimated annual payout of CN¥0.35 per share.

When is the next ex-dividend date for Zhejiang DiAn Diagnostics Co (300244)?

The next ex-dividend date is scheduled for June 25, 2027.

How did Zhejiang DiAn Diagnostics Co (300244) perform in its most recent earnings report?

In the last report (March 31, 2026), Zhejiang DiAn Diagnostics Co posted an EPS surprise of -140% and a revenue surprise of -10.2%.

What is Zhejiang DiAn Diagnostics Co (300244) beta (volatility) score?

Zhejiang DiAn Diagnostics Co has a beta of 0.693, indicating lower volatility than the overall market.